Serum tartrate-resistant acid phosphatase and bone mineral content in postmenopausal osteoporosis.
Serum tartrate-resistant acid phosphatase (sTr-AcP) and bone mineral content (BMC) were measured in 29 women with postmenopausal osteoporosis and in 12 control women. Serum Tr-AcP was higher in osteoporotic patients than in controls and a negative linear correlation was found between sTr-AcP and BMC in osteoporotic women. These results suggest that sTr-AcP could be a useful marker for bone loss and consequently, for the measure of bone resorption rate in postmenopausal women.
de la Piedra
C
C
Unidad Metabólica, Fundación Jimenez Díaz, Madrid, Spain.
Torres
R
R
Rapado
A
A
Diaz Curiel
M
M
Castro
N
N
D000135:Acid Phosphatase / Q000097:blood*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001842:Bone and Bones / Q000032:analysis* / Q000378:metabolism; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008875:Middle Aged; D008903:Minerals / Q000032:analysis* / Q000378:metabolism; D010024:Osteoporosis / Q000378:metabolism*; D013644:Tartrates / Q000494:pharmacology*
D008903:Minerals; D013644:Tartrates; D000135:Acid Phosphatase